A Study of Microalbuminuria (MAU) and Advanced Glycation End Products (AGEs) Levels in Diabetic and Hypertensive

S Gawandi1, S Gangawane2, A Chakrabarti2

  • 11Radiation Medicine Centre, Bhabha Atomic Research Centre (BARC), Mumbai, India.

Insights

Early detection of kidney damage in diabetes mellitus (DM), hypertension (HTN), and pregnancy-induced hypertension (PIH) is crucial. Screening for microalbuminuria (MAU) and advanced glycation end products (AGEs) can help identify at-risk patients.

Area of Science:

  • Nephrology
  • Endocrinology
  • Clinical Chemistry

Background:

  • Non-communicable diseases like diabetes mellitus (DM) and hypertension (HTN) are globally prevalent and can lead to nephropathy.
  • Microalbuminuria (MAU) is an early indicator of kidney damage, while advanced glycation end products (AGEs) are important prognostic factors in diabetic nephropathy.

Purpose of the Study:

  • To evaluate microalbuminuria (MAU) and advanced glycation end products (AGEs) as early biomarkers for nephropathy in patients with DM, HTN, and pregnancy-induced hypertension (PIH).

Main Methods:

  • Serum levels of MAU and Nε-Carboxymethyllysine (CML) were measured using in-house RIA kits.
  • Total AGEs in serum were quantified using ELISA.
  • Levels were compared between patient groups (DM, HTN, PIH) and healthy controls.

Main Results:

  • MAU, CML, and AGE-BSA levels were significantly elevated (p < 0.001) in DM, HTN, and PIH subjects compared to controls.
  • Increased serum CML and AGEs suggest ongoing glycemic damage and susceptibility to renal complications.

Conclusions:

  • Elevated MAU and AGEs (including CML) serve as valuable early indicators of nephropathy risk in DM, HTN, and PIH.
  • These biomarkers facilitate early clinical diagnosis and intervention to prevent renal complications.

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
164
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
614
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.7K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
844
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
972
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.1K